A cut-off value of 54.43% was established and relatively high sensitivity (100%), specificity (100%) were obtained, Accordingly, p16INK4a could be an applicable surrogate marker to discern CIN from other similar tumors and assess the risk of CIN 2–3. This evidence concerns the gene CDKN2A and cervical squamous intraepithelial neoplasia.